Basics |
Company: |
Applied Therapeutics, Inc. Common Stock |
IPO Date: |
May 13, 2019 |
Sector: |
Healthcare |
Industry: |
Biotech |
Market Cap: |
$61.67M |
Activated in VL: |
True |
Average Daily Range |
Avg Daily Range: |
$0.48 | 4.18%
|
Avg Daily Range (30 D): |
$0.03 | 4.47%
|
Avg Daily Range (90 D): |
$0.14 | 4.00%
|
Institutional Daily Volume |
Avg Daily Volume: |
.68M |
Avg Daily Volume (30 D): |
3.99M |
Avg Daily Volume (90 D): |
4.67M |
Trade Size |
Avg Trade Size (Sh.): |
179 |
Avg Trade Size (Sh.) (30 D): |
415 |
Avg Trade Size (Sh.) (90 D): |
275 |
Institutional Trades |
Total Inst.Trades: |
401 |
Avg Inst. Trade: |
$2.02M |
Avg Inst. Trade (30 D): |
$1.24M |
Avg Inst. Trade (90 D): |
$1.81M |
Avg Inst. Trade Volume: |
.34M |
Avg Inst. Trades (Per Day): |
1 |
Market Closing Trades |
Avg Closing Trade: |
$2.35M |
Avg Closing Trade (30 D): |
$1.15M |
Avg Closing Trade (90 D): |
$1.4M |
Avg Closing Volume: |
372.66K |
|
|
|
|
Financials |
|
TTM |
Q3 2024 |
Q2 2024 |
Basic EPS
|
$-1.46
|
$-.48
|
$.02
|
Diluted EPS
|
$-1.61
|
$-.48
|
$-.13
|
Revenue
|
$ -.21M
|
$ .12M
|
$ .14M
|
Gross Profit
|
$
|
$
|
$
|
Net Income / Loss
|
$ -187.31M
|
$ -68.59M
|
$ 2.9M
|
Operating Income / Loss
|
$ -92.28M
|
$ -29.74M
|
$ -20.44M
|
Cost of Revenue
|
$
|
$
|
$
|
Net Cash Flow
|
$ 12.44M
|
$ M
|
$ M
|
PE Ratio
|
|
|
|
|